Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,973 | -24,105 | -9,160 | -28,006 | -17,479 |
| Depreciation Amortization | 1,735 | 891 | 364 | 532 | 253 |
| Accounts payable and accrued liabilities | 1,413 | 1,162 | 354 | -164 | -37 |
| Other Working Capital | 1,187 | 5,297 | -309 | -3 | 479 |
| Other Operating Activity | 5,874 | 3,891 | 2,129 | 11,013 | 5,113 |
| Operating Cash Flow | $-25,764 | $-12,864 | $-6,622 | $-16,628 | $-11,671 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -200,689 | -47,816 | -13,428 | -83,317 | -26,418 |
| PPE Investments | -19 | -5 | -5 | -46 | -10 |
| Investing Cash Flow | $-200,708 | $-47,821 | $-13,433 | $-83,363 | $-26,428 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 263,629 | 69,445 | 69,487 | 56,455 | N/A |
| Other Financing Activity | -4,588 | -4,468 | 0 | 13,818 | 12,187 |
| Financing Cash Flow | $259,041 | $64,977 | $69,487 | $70,273 | $12,187 |
| Beginning Cash Position | 21,897 | 21,897 | 21,897 | 51,615 | 51,615 |
| End Cash Position | 54,466 | 26,189 | 71,329 | 21,897 | 25,703 |
| Net Cash Flow | $32,569 | $4,292 | $49,432 | $-29,718 | $-25,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,764 | -12,864 | -6,622 | -16,628 | -11,671 |
| Capital Expenditure | -19 | -5 | -5 | -46 | -10 |
| Free Cash Flow | -25,783 | -12,869 | -6,627 | -16,674 | -11,681 |